Clinical Trial Detail

NCT ID NCT02307474
Title A Pilot Study of SBRT With Adjuvant Pazopanib for Renal Cell Cancer
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Case Comprehensive Cancer Center
Indications

clear cell renal cell carcinoma

Therapies

Pazopanib

Age Groups: adult

No variant requirements are available.